This program will expire and must be completed by 12/31/27.

Please note this program was a part of the OPSO 2024 Annual Conference. 

Learning Objectives:

• Explain the basics of the pathophysiology of CAD
• Discuss risk factors and how we use them to predict risk of symptomatic CAD.
• Appropriate selection of non-invasive testing to further risk stratify asymptomatic patients without CAD.

Dr. Hudson has no financial relationships or affiliations to disclose.

Accreditation Statement: The Osteopathic Physicians and Surgeons of Oregon is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians and designates this program for a maximum of 1.0 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician's participation in this activity.

Grievance Policy:
All grievances may be directed to OPSO Executive Director at info@opso.org. All grievances will receive an initial response within 30 days of receipt.  If the participant does not receive a satisfactory response, they can submit a complaint to the Bureau of Osteopathic Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.

Planning Disclosure:
The OPSO CME Committee consisting of representatives from the Osteopathic Physicians and Surgeons of Oregon (OPSO), has no relevant financial relationships with any organization producing, marketing, reselling, distributing health care goods or services consumed by, or used on, patients relative to the content of these presentations.